CoChat
Sign Up
Cited by 28COVID-19 epidemiological studiesPublic Health Policies and EducationCOVID-19 Prevention and Impact

Factors influencing international collaboration on the prevention of COVID-19

Open access
Hameed, M., Najafi, M., Cheeti, S., Sheokand, A., Mago, A., Desai, S.·2022·Public Health
DOI 10.1016/j.puhe.2022.08.017PMC PMC9458694
Open this paper in CoChat — free account

Abstract

Objectives COVID-19 has spread rapidly throughout the world, which has highlighted the importance of collaboration between countries to prevent further transmission of the virus. This review aims to identify the factors that influence international collaboration between policymakers for COVID-19 prevention and consider strategies to manage pandemics in the future. Study design A scoping review was conducted using the Arksey and O'Malley framework for scoping reviews. Methods A literature search was performed across PubMed, Google Scholar, Scopus and Embase databases using relevant keywords. The initial search identified 1010 articles; after selection criteria were applied, 28 studies were included in the review. Results Most of the selected articles were literature reviews, and China had the greatest contribution of articles to this study. The following seven key categories influencing international collaboration were identified: political, structure, infrastructure, leadership and governance, knowledge and information sharing, community engagement, and process/action. Conclusion Leadership and governance was the most important factor identified in international collaboration between countries. In addition, knowledge and information sharing were seen to help avoid repetition of negative situations experienced in other countries. Moreover, controlling COVID-19 on a global scale is more likely to be achieved when there are sufficient structures and resources and when appropriate communication between countries, health systems and communities is used. This collaboration can also greatly benefit low- and middle-income countries where resources and expertise are often limited.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.puhe.2022.08.017

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Addressing the case of infectious disease syndemics of COVID-19 requires collaborations across the health, environment, and social science fields.

    “Addressing the case of infectious disease syndemics of COVID-19, for example, requires collaborations across the health, environment, and social science fields [35,77].”

    From Is Pollution the Primary Driver of Infectious Syndemics? (2024) · cites this paper as [77]

    The Discussion (Leadership and governance) recommends a multistakeholder, multidisciplinary approach to COVID-19, and the Results (Process/action) call for multisectoral action. The paper does not specifically discuss infectious-disease syndemics or identify collaboration across the health, environment, and social science fields. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 36

  1. [3]Abdelhafiz A.S. Abd ElHafeez S. Khalil M.A. Shahrouri M. Alosaim B. Salem R.O. Factors influencing participation in COVID-19 clinical trials: a multi-national study Front Med 8 2021 608959 10.3389/fmed.2021.608959 Published 2021 Feb 23 PMC7940528 33708777 · DOI
  2. [4]Koplan J.P. Bond T.C. Merson M.H. Reddy K.S. Rodriguez M.H. Sewankambo N.K. Towards a common definition of global health Lancet 373 9679 2009 1993 1995 10.1016/S0140-6736(09)60332-9 19493564 PMC9905260 · DOI · Paper page
  3. [5]Frenk J. Gómez-Dantés O. Moon S. From sovereignty to solidarity: a renewed concept of global health for an era of complex interdependence 2014 https://linkinghub.elsevier.com/retrieve/pii/S0140-6736(13)62561-1 24388312
  4. [6]Stuckler D. McKee M. Five metaphors about global-health policy Lancet 372 9633 2008 95 97 10.1016/S0140-6736(08)61013-2 18620934 PMC7136987 · DOI
  5. [7]Bump J.B. Friberg P. Harper D.R. International collaboration and COVID-19: what are we doing and where are we going? BMJ 372 2021 n180 10.1136/bmj.n180 Published 2021 Jan 28 33509953 PMC7842258 · DOI
  6. [9]Mejia R. Hotez P. Bottazzi M.E. Global COVID-19 efforts as the platform to achieving the sustainable development Goals [published online ahead of print, 2020 Aug 20] Curr Trop Med Rep 2020 1 5 10.1007/s40475-020-00209-y PMC7440684 32844081 · DOI
  7. [10]Usher A.D. WHO launches crowdfund for COVID-19 response Lancet 395 10229 2020 1024 10.1016/S0140-6736(20)30719-4 32222188 PMC7194571 · DOI
  8. [14]Armstrong R. Hall B.J. Doyle J. Waters E. Cochrane Update. 'Scoping the scope' of a cochrane review J Public Health 33 1 2011 147 150 10.1093/pubmed/fdr015 21345890 · DOI · Paper page
  9. [16]The Lancet Global collaboration for health: rhetoric versus reality Lancet 396 10253 2020 735 10.1016/S0140-6736(20)31900-0 32919496 · DOI
  10. [17]Carroll D. Morzaria S. Briand S. Johnson C.K. Morens D. Sumption K. Preventing the next pandemic: the power of a global viral surveillance network BMJ 372 2021 n485 10.1136/bmj.n485 Published 2021 Mar 12 33712471 PMC7953426 · DOI
  11. [18]Collins T. Akselrod S. Bloomfield A. Gamkrelidze A. Jakab Z. Placella E. Rethinking the COVID-19 pandemic: Back to public health Ann Glob Health 86 1 2020 133 10.5334/aogh.3084 Published 2020 Oct 8 33102153 PMC7546103 · DOI
  12. [19]Hotez P.J. Batista C. Amor Y.B. Ergonul O. Figueroa J.P. Gilbert S. Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic EClinicalMedicine 39 2021 101053 10.1016/j.eclinm.2021.101053 PMC8330385 34368661 · DOI
  13. [20]Zhou S. Han L. Liu P. Zheng Z.J. Global health governance for travel health: lessons learned from the coronavirus disease 2019 (COVID-19) outbreaks in large cruise ships Glob Health J 4 4 2020 133 138 10.1016/j.glohj.2020.11.006 33294249 PMC7709727 · DOI
  14. [21]Pyone T. Aung T.T. Endericks T. Myint N.W. Inamdar L. Collins S. Health system governance in strengthening International Health Regulations (IHR) compliance in Myanmar BMJ Glob Health 5 11 2020 e003566 10.1136/bmjgh-2020-003566 PMC7607592 33139302 · DOI
  15. [22]AlKhaldi M. James N. Chattu V.K. Ahmed S. Meghari H. Kaiser K. Rethinking and strengthening the Global Health Diplomacy through triangulated nexus between policy makers, scientists and the community in light of COVID-19 global crisis glob health res policy 6 2021 12 10.1186/s41256-021-00195-2 33845923 PMC8041471 · DOI
  16. [24]Tartari E. Hopman J. Allegranzi B. Gao B. Widmer A. Cheng V.C. Perceived challenges of COVID-19 infection prevention and control preparedness: a multinational survey J Glob Antimicrob Resist 22 2020 779 781 10.1016/j.jgar.2020.07.002 32659504 PMC7351656 · DOI
  17. [25]Yu Z. Wang G. Goldman E. Zangerl B. Xie N. Cao Y. COVID-19 vaccine: call for employees in international transportation industries and international travelers as the first priority in global distribution Open Med 16 1 2021 134 138 10.1515/med-2021-0210 Published 2021 Jan 11 PMC7811367 33521319 · DOI
  18. [26]Da'ar O.B. Haji M. Jradi H. Coronavirus Disease 2019 (COVID-19): potential implications for weak health systems and conflict zones in the Middle East and North Africa region Int J Health Plann Manage 35 5 2020 1240 1245 10.1002/hpm.2982 32557820 PMC7323081 · DOI
  19. [27]Sharma O. Sultan A.A. Ding H. Triggle C.R. A review of the progress and challenges of developing a vaccine for COVID-19 Front Immunol 11 2020 585354 10.3389/fimmu.2020.585354 Published 2020 Oct 14 PMC7591699 33163000 · DOI
  20. [28]Rios R.S. Zheng K.I. Zheng M.H. Data sharing during COVID-19 pandemic: what to take away Expert Rev Gastroenterol Hepatol 14 12 2020 1125 1130 10.1080/17474124.2020.1815533 32842793 · DOI
  21. [29]Ros F. Kush R. Friedman C. Gil Zorzo E. Rivero Corte P. Rubin J.C. Addressing the Covid-19 pandemic and future public health challenges through global collaboration and a data-driven systems approach [published online ahead of print, 2020 Dec 6] Learn Health Syst 5 1 2020 e10253 10.1002/lrh2.10253 PMC7744897 33349796 · DOI
  22. [30]Henley P. Igihozo G. Wotton L. One Health approaches require community engagement, education, and international collaborations-a lesson from Rwanda Nat Med 27 6 2021 947 948 10.1038/s41591-021-01350-5 34017132 · DOI
  23. [31]Morello B.R. Milazzo A. Marshall H.S. Giles L.C. Lessons for and from the COVID-19 pandemic response - an appraisal of guidance for the public health management of Invasive Meningococcal Disease J Infect Public Health 14 8 2021 1069 1074 10.1016/j.jiph.2021.06.014 34218099 PMC8230839 · DOI
  24. [32]Austin C.C. Bernier A. Bezuidenhout L. Bicarregui J. Biro T. Cambon-Thomsen A. Fostering global data sharing: highlighting the recommendations of the Research Data Alliance COVID-19 working group Wellcome Open Res 5 2021 267 10.12688/wellcomeopenres.16378.2 Published 2021 May 26 33501381 PMC7808050 · DOI
  25. [33]Lie R.K. Miller F.G. Allocating a COVID-19 vaccine: Balancing national and international Responsibilities Milbank Q 99 2 2021 450 466 10.1111/1468-0009.12494 33295679 PMC8241277 · DOI
  26. [34]Hu G. Qiu W. From guidance to practice: Promoting risk communication and community engagement for prevention and control of coronavirus disease (COVID-19) outbreak in China J Evid Based Med 13 2 2020 168 172 10.1111/jebm.12387 32445287 PMC7280730 · DOI
  27. [35]Fanning J.P. Murthy S. Obonyo N.G. Baillie J.K. Webb S. Dalton H.J. Global infectious disease research collaborations in crises: building capacity and inclusivity through cooperation Global Health 17 1 2021 84 10.1186/s12992-021-00731-2 Published 2021 Jul 26 34311748 PMC8313114 · DOI
  28. [36]Liu X. Chang Y.C. An emergency responding mechanism for cruise epidemic prevention-taking COVID-19 as an example Mar Policy 119 2020 104093 10.1016/j.marpol.2020.104093 PMC7306194 32834406 · DOI
  29. [37]Vervoort D. Ma X. Luc J.G.Y. COVID-19 pandemic: a time for collaboration and a unified global health front Int J Qual Health Care 33 1 2021 10.1093/intqhc/mzaa065 mzaa065 PMC7337739 32592480 · DOI
  30. [38]Nhamo G. Chikodzi D. Kunene H.P. Mashula N. COVID-19 vaccines and treatments nationalism: challenges for low-income countries and the attainment of the SDGs Glob Public Health 16 3 2021 319 339 10.1080/17441692.2020.1860249 33317389 · DOI
  31. [39]Kinsella C.M. Santos P.D. Postigo-Hidalgo I. Folgueiras-González A. Passchier T.C. Szillat K.P. Preparedness needs research: How fundamental science and international collaboration accelerated the response to COVID-19 PLoS Pathog 16 10 2020 e1008902 10.1371/journal.ppat.1008902 PMC7546461 33035262 · DOI
  32. [40]Bernardo T. Sobkowich K.E. Forrest R.O. Stewart L.S. D'Agostino M. Perez Gutierrez E. Collaborating in the time of COVID-19: the scope and scale of Innovative responses to a global pandemic JMIR Public Health Surveill 7 2 2021 e25935 10.2196/25935 Published 2021 Feb 9 33503001 PMC7879722 · DOI
  33. [41]Zhang S. Wang Z. Chang R. Wang H. Xu C. Yu X. COVID-19 containment: China provides important lessons for global response Front Med 14 2 2020 215 219 10.1007/s11684-020-0766-9 32212059 PMC7095399 · DOI
  34. [42]Tritschler T. Mathieu M.E. Skeith L. Rodger M. Middeldorp S. Brighton T. Anticoagulant interventions in hospitalized patients with COVID-19: a scoping review of randomized controlled trials and call for international collaboration J Thromb Haemost 18 11 2020 2958 2967 10.1111/jth.15094 32888372 PMC9906402 · DOI
  35. [43]AlTakarli Nourah S. China's response to the COVID-19 outbreak: a Model for epidemic preparedness and management Dubai Medical Journal 3 2020 1 6 10.1159/000508448 · DOI
  36. [44]Ahmad R. Atun R.A. Birgand G. Castro-Sánchez E. Charani E. Ferlie E.B. Macro level influences on strategic responses to the COVID-19 pandemic - an international survey and tool for national assessments J Glob Health 11 2021 05011 10.7189/jogh.11.05011 Published 2021 Jul 1 PMC8248749 34221358 · DOI

Cited by

Sorted by citations

Authors
Hameed, M., Najafi, M., Cheeti, S., Sheokand, A., Mago, A., & Desai, S.
Affiliations
  • Alfaisal University (SA)
  • Tehran University of Medical Sciences (IR)
  • Manipal Academy of Higher Education (IN)
  • Jawaharlal Nehru Medical College (IN)
  • Pramukhswami Medical College (IN)
Corresponding author
Hameed, M.
ORCID
Venue
Public Health
Publisher
Elsevier BV
Published
2022-11
Volume
212
Pages
95-101
ISSN
0033-3506 (ISSN-L)
DOI
10.1016/j.puhe.2022.08.017
PMC
PMC9458694
OpenAlex
W4295211093
Cited by
28
References
3
Citations by year
2026: 5 · 2025: 10 · 2024: 11 · 2023: 1 · 2022: 1
FWCI
0.62
Type
journal article
Language
en
Open access
Licence
Locations
  • Public Health (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
  • Health Sciences › Health Professions › General Health Professions › Public Health Policies and Education
  • Social Sciences › Sociology and Political Science › COVID-19 Prevention and Impact
Keywords
COVID-19 pandemic, international cooperation, pandemic prevention, global health governance, leadership, knowledge sharing, information sharing, community participation, health infrastructure, low- and middle-income countries, cross-border communication
MeSH terms
COVID-19, China, Communication, Humans, Medical Assistance, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review